PATENTED TECHNOLOGY
Ovation’s ovarian cancer diagnostic technology is supported by a robust portfolio of patents. It is the only patented technology for measuring Bcl-2 levels in urine for the purpose of detecting ovarian cancer.
The US patent was granted in 2011 and it is supported by international patents in the following countries:
- Brazil
- China
- Germany
- India
- Canada
- France
- Great Britain
- Mexico